“We take our responsibilities in the world seriously and always strive to do what is right. We do this for our customers, for our employees, for the environment, for our families and friends, and, for the communities in which we operate.”
~Bristol-Meyer Squibb ~
“To offset the approaching patent “cliff,” as the industry calls it, Bristol decided in 2007 on a twin strategy of cost-cutting and strategic acquisitions. The company reported productivity savings of $1.2 billion in 2008, largely through staff cuts and the shuttering of manufacturing plants. It plans further cuts and savings totaling $1.3 billion by 2012.”
This included shuttering down the Compassionate Care Use of Ipilimumab on 8-12-2008. I believe there was no shortage. They took the opportunity to save on the bottom line instead of saving some Melanoma Patients. They seem not care about the patients as much as their bottom line. They say the take their responsibilities in the world seriously.
PROVE IT. Return the compassionate drug to the patients that need it the most. By doing so, Bristol Meyer Squibb will get more back than just money for the bottom-line. They will get back their loyal consumers. This not about money, this about doing what is right and ethical.
I urge Bristol-Meyer Squibb to do what is right and not just give us lip service.
Please take the time to sign the E-Petition this Holiday Season. We won’t stop until the injustice has been righted. As a consumer of BMS products we can make a difference
Take Care,
Jimmy B
No comments:
Post a Comment